Clarient receives patent for Mammostrat breast cancer prognostic test
Clarient receives patent for Mammostrat breast cancer prognostic test
Clarient, Inc. a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that the United States Patent and Trademark Office and the European Patent Office have allowed patents covering the technology behind Clarient Insight Dx Mammostrat, a test designed to aid in the classification of the risk of recurrence of breast cancer …
Read more on News-Medical-Net
Categories: Breast Cancer In Men Tags: breast, cancer, Clarient, Mammostrat, Patent, Prognostic, receives, test
Manuscript based on study of Clarient InsightDx Mammostrat to be published in Breast Cancer Research
Manuscript based on study of Clarient InsightDx Mammostrat to be published in Breast Cancer Research
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that a manuscript based on a study of Clarient InsightDx Mammostrat, a test used to classify the risk of recurrence of breast cancer following surgery and chemotherapy, will be published in an upcoming edition of Breast Cancer Research, a prominent peer …
Read more on News-Medical-Net
Categories: Breast Cancer Tumor Tags: based, breast, cancer, Clarient, InsightDx, Mammostrat, Manuscript, Published, research, Study